CDH1 and colon adenocarcinoma: In order to validate the inhibition of ZEB1 on CDH1 upon EMT, we examined by RT-qPCR a cohort of 30 colon adenocarcinoma patients with stage 3/4 prior to any chemotherapy and not associated with high-risk hereditary mutations (Table 1).